Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.36 USD | +2.30% | +5.89% | -9.44% |
02:17pm | Bausch + Lomb's New Intraocular Lens Approved by Health Canada | MT |
01:08pm | Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.44% | 5.28B | |
-7.60% | 181B | |
-0.45% | 108B | |
-7.15% | 66.12B | |
+2.95% | 50.65B | |
+5.14% | 43.11B | |
+3.49% | 40.74B | |
+19.89% | 31.6B | |
+16.38% | 25.56B | |
-6.83% | 24.16B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Q4 Revenue of US$1.173 Billion; GAAP Net Loss Attributable to Co of $54 Million; Provides 2024 Guidance